Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a -9.144% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a: c1ccc(C2[C@H]3CN(CC4CCCCC4)[C@H](c4ccccc4)C34CC2(c2cccnc2)C4)cc1
b: O=C(CCc1nc(-c2ccccc2)no1)NCc1ccco1
c: CCc1ccc(NC(=O)CSc2nnc(-c3cccs3)n2CC)cc1
d: COc1ccc(Cc2nnc(NC(C)=O)s2)cc1
e: CCCN(CCC)C(=O)c1cc2c(=O)[nH]c3ccc(C)cc3c2s1
Answer: a. c1ccc(C2[C@H]3CN(CC4CCCCC4)[C@H](c4ccccc4)C34CC2(c2cccnc2)C4)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
c1ccc(C2[C@H]3CN(CC4CCCCC4)[C@H](c4ccccc4)C34CC2(c2cccnc2)C4)cc1
c1ccc(C2[C@H]3CN(CC4CCCCC4)[C@H](c4ccccc4)C34CC2(c2cccnc2)C4)cc1
(2S,5R)-3-(cyclohexylmethyl)-2,6-diphenyl-7-pyridin-3-yl-3-azatricyclo[5.1.1.01,5]nonane